Variant report

Variant	esv3360992
Chromosome Location	chr19:45418805-45430721
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:389)
CpG islands
(count:367)
Chromatin interactive
region (count:9)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:389 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:45428702-45429030	HepG2	liver:	n/a	n/a
2	ARID3A	chr19:45427454-45427972	HepG2	liver:	n/a	n/a
3	ARID3A	chr19:45424155-45424271	HepG2	liver:	n/a	n/a
4	ATF1	chr19:45430291-45430704	K562	blood:	n/a	n/a
5	BACH1	chr19:45430428-45430782	H1-hESC	embryonic stem cell:	n/a	n/a
6	BHLHE40	chr19:45430359-45430651	K562	blood:	n/a	n/a
7	BHLHE40	chr19:45430362-45430644	HepG2	liver:	n/a	n/a
8	BHLHE40	chr19:45428627-45429047	HepG2	liver:	n/a	n/a
9	BHLHE40	chr19:45430407-45430643	GM12878	blood:	n/a	n/a
10	BHLHE40	chr19:45427445-45427908	HepG2	liver:	n/a	n/a
11	BRCA1	chr19:45430353-45430648	Hela-S3	cervix:	n/a	n/a
12	BRCA1	chr19:45427503-45427772	HepG2	liver:	n/a	n/a
13	CBX3	chr19:45422679-45423180	K562	blood:	n/a	n/a
14	CEBPB	chr19:45427547-45427779	HepG2	liver:	n/a	n/a
15	CEBPB	chr19:45423229-45423569	K562	blood:	n/a	chr19:45423390-45423401
16	CEBPB	chr19:45427391-45427865	HepG2	liver:	n/a	n/a
17	CEBPB	chr19:45429037-45429280	HepG2	liver:	n/a	n/a
18	CEBPB	chr19:45428608-45429316	HepG2	liver:	n/a	chr19:45428766-45428777
19	CEBPB	chr19:45423304-45423493	ECC-1	luminal epithelium:	n/a	chr19:45423390-45423401
20	CEBPB	chr19:45423241-45423568	HepG2	liver:	n/a	chr19:45423390-45423401
21	CEBPB	chr19:45428525-45429014	HepG2	liver:	n/a	chr19:45428766-45428777
22	CEBPB	chr19:45423242-45423463	HepG2	liver:	n/a	chr19:45423390-45423401
23	CEBPB	chr19:45428640-45428910	K562	blood:	n/a	chr19:45428766-45428777
24	CEBPB	chr19:45428605-45429317	HepG2	liver:	n/a	chr19:45428766-45428777
25	CEBPB	chr19:45429128-45429295	H1-hESC	embryonic stem cell:	n/a	n/a
26	CEBPB	chr19:45427499-45427849	HepG2	liver:	n/a	n/a
27	CEBPB	chr19:45428637-45428963	HepG2	liver:	n/a	chr19:45428766-45428777
28	CEBPB	chr19:45423189-45423505	HepG2	liver:	n/a	chr19:45423390-45423401
29	CEBPB	chr19:45428659-45428929	A549	lung:	n/a	chr19:45428766-45428777
30	CEBPB	chr19:45429140-45429308	K562	blood:	n/a	n/a
31	CEBPB	chr19:45428625-45428871	H1-hESC	embryonic stem cell:	n/a	chr19:45428766-45428777
32	CEBPB	chr19:45423333-45423553	IMR90	lung:	n/a	chr19:45423390-45423401
33	CEBPB	chr19:45428612-45429310	IMR90	lung:	n/a	chr19:45428766-45428777
34	CEBPB	chr19:45423316-45423491	MCF-7	breast:	n/a	chr19:45423390-45423401
35	CEBPB	chr19:45423389-45423410	A549	lung:	n/a	chr19:45423390-45423401
36	CEBPD	chr19:45427489-45427791	HepG2	liver:	n/a	n/a
37	CEBPD	chr19:45427480-45427942	HepG2	liver:	n/a	n/a
38	CEBPD	chr19:45428486-45429103	HepG2	liver:	n/a	chr19:45428765-45428776 chr19:45428803-45428814
39	CEBPD	chr19:45428576-45428995	HepG2	liver:	n/a	chr19:45428765-45428776 chr19:45428803-45428814
40	CHD2	chr19:45430355-45430668	Hela-S3	cervix:	n/a	n/a
41	CHD2	chr19:45430403-45430616	GM12878	blood:	n/a	n/a
42	CHD2	chr19:45430482-45430619	HepG2	liver:	n/a	n/a
43	CHD2	chr19:45428668-45428990	HepG2	liver:	n/a	n/a
44	CHD2	chr19:45427392-45427887	HepG2	liver:	n/a	n/a
45	CHD2	chr19:45430354-45430696	K562	blood:	n/a	n/a
46	CHD2	chr19:45430349-45430701	H1-hESC	embryonic stem cell:	n/a	n/a
47	CREB1	chr19:45430341-45430787	A549	lung:	n/a	n/a
48	CREB1	chr19:45430362-45430807	GM12878	blood:	n/a	n/a
49	CREB1	chr19:45430322-45430826	K562	blood:	n/a	n/a
50	CREB1	chr19:45430319-45430749	K562	blood:	n/a	n/a

(count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:45429870-45429920	PFSK-1	brain:	n/a
2	chr19:45429870-45429920	PFSK-1	brain:	n/a
3	chr19:45428924-45428974	HIPEpiC	eye:	n/a
4	chr19:45428924-45428974	HMEC	breast:	n/a
5	chr19:45428924-45428974	NT2-D1	testis:	n/a
6	chr19:45429910-45429960	AG04449	skin:	fetal
7	chr19:45428924-45428974	ovcar-3	ovarian:	n/a
8	chr19:45429870-45429920	MCF-7	breast:	n/a
9	chr19:45429771-45429821	HCF	heart:	n/a
10	chr19:45429910-45429960	GM19239	blood:	n/a
11	chr19:45429910-45429960	AG09319	gingival:	n/a
12	chr19:45429870-45429920	ProgFib	skin:	n/a
13	chr19:45429870-45429920	HRPEpiC	eye:	n/a
14	chr19:45429910-45429960	HepG2	liver:	n/a
15	chr19:45430113-45430163	HIPEpiC	eye:	n/a
16	chr19:45429771-45429821	AG04449	skin:	fetal
17	chr19:45429910-45429960	HEEpiC	esophagus:	n/a
18	chr19:45429910-45429960	GM12892	blood:	n/a
19	chr19:45429870-45429920	Hepatocyte	liver:	n/a
20	chr19:45430113-45430163	PrEC	prostate:	n/a
21	chr19:45430113-45430163	ovcar-3	ovarian:	n/a
22	chr19:45429910-45429960	PFSK-1	brain:	n/a
23	chr19:45429910-45429960	A549	lung:	n/a
24	chr19:45429771-45429821	A549	lung:	n/a
25	chr19:45430113-45430163	NHDF-neo	bronchial:	n/a
26	chr19:45429870-45429920	SK-N-SH_RA	brain:	n/a
27	chr19:45430113-45430163	Jurkat	blood:	n/a
28	chr19:45429870-45429920	NHBE	bronchial:	n/a
29	chr19:45428924-45428974	U87	brain:	n/a
30	chr19:45429870-45429920	CMK	blood:	n/a
31	chr19:45422541-45422591	MCF-7	breast:	n/a
32	chr19:45422541-45422591	A549	lung:	n/a
33	chr19:45430113-45430163	AG04450	lung:	fetal
34	chr19:45429910-45429960	HL-60	blood:	n/a
35	chr19:45422541-45422591	GM12892	blood:	n/a
36	chr19:45430113-45430163	LNCaP	prostate:	n/a
37	chr19:45428924-45428974	AG04449	skin:	fetal
38	chr19:45429870-45429920	HCM	heart:	n/a
39	chr19:45429910-45429960	HRCEpiC	kidney:	n/a
40	chr19:45429870-45429920	HL-60	blood:	n/a
41	chr19:45429870-45429920	MCF10A-Er-Src	breast:	n/a
42	chr19:45429771-45429821	SK-N-SH_RA	brain:	n/a
43	chr19:45430113-45430163	SK-N-SH	brain:	n/a
44	chr19:45429910-45429960	SAEC	small airway:	n/a
45	chr19:45430113-45430163	HPAEpiC	pulmonary alveolar:	n/a
46	chr19:45428924-45428974	ProgFib	skin:	n/a
47	chr19:45430113-45430163	MCF10A-Er-Src	breast:	n/a
48	chr19:45428924-45428974	T-47D	breast:	n/a
49	chr19:45429870-45429920	NT2-D1	testis:	n/a
50	chr19:45429910-45429960	LNCaP	prostate:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:45407631..45409490-chr19:45429198..45431974,3	K562	blood:
2	chr19:45428887..45430724-chr19:45458504..45460514,2	MCF-7	breast:
3	chr19:45425754..45427401-chr19:45457007..45459341,2	MCF-7	breast:
4	chr19:45407631..45409490-chr19:45429549..45431974,2	K562	blood:
5	chr19:45391987..45395479-chr19:45416556..45421203,6	K562	blood:
6	chr19:45420587..45422636-chr19:45425873..45427506,2	K562	blood:
7	chr19:45428614..45431090-chr19:45445301..45448167,2	K562	blood:
8	chr19:45420587..45422636-chr19:45425873..45427506,2	K562	blood:
9	chr19:45409319..45412903-chr19:45425106..45429142,3	K562	blood:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC011481.1-1	chr19:45430060-45430290	NONHSAT066738
2	lnc-AC011481.1-1	chr19:45430213-45430290	NONHSAT066739
3	lnc-APOC1-1	chr19:45422430-45422606	NONHSAT066734
4	lnc-AC011481.1-1	chr19:45430213-45430290	NONHSAT066737
5	lnc-AC011481.1-1	chr19:45430060-45430290	NONHSAT066736
6	lnc-AC011481.1-1	chr19:45430060-45430089	NONHSAT066737
7	lnc-AC011481.1-1	chr19:45430077-45430086	NONHSAT066739

No data

Variant related genes	Relation type
APOC1P1	TF binding region
APOC1P1	CpG island
ENSG00000104853	chromatin interactions
ENSG00000267114	chromatin interactions
ENSG00000224916	chromatin interactions
ENSG00000267467	chromatin interactions
ENSG00000130204	chromatin interactions
ENSG00000267282	chromatin interactions
ENSG00000130203	chromatin interactions

Extended variants
information (count: 499 )
Associated
traits (count: 76 )

Variant overlapped rSNPs/rCNVs (count:499 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs5118	chr19:45418844-45418845	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs181324013	chr19:45418846-45418847	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs536562430	chr19:45418886-45418887	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs556781141	chr19:45418946-45418947	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs3826688	chr19:45418961-45418962	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs8107634	chr19:45418988-45418989	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs8107841	chr19:45418995-45418996	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs8107549	chr19:45418999-45419000	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs368575738	chr19:45419096-45419097	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs5119	chr19:45419107-45419108	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs77882010	chr19:45419168-45419169	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs545536296	chr19:45419185-45419186	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs185495905	chr19:45419216-45419217	Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs371220643	chr19:45419272-45419273	Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs375780016	chr19:45419318-45419319	Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs544207008	chr19:45419319-45419320	Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs576179024	chr19:45419326-45419327	Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs376127005	chr19:45419394-45419395	Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs554447377	chr19:45419395-45419396	Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs541112130	chr19:45419410-45419411	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs560974467	chr19:45419411-45419412	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs371452873	chr19:45419413-45419414	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs374680882	chr19:45419414-45419415	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs530077962	chr19:45419441-45419442	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs72654455	chr19:45419476-45419477	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs375197804	chr19:45419524-45419525	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs143606600	chr19:45419528-45419529	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs369438021	chr19:45419549-45419550	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs72654456	chr19:45419555-45419556	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs531411684	chr19:45419582-45419583	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs113318070	chr19:45419584-45419585	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs201661762	chr19:45419604-45419605	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs375519463	chr19:45419605-45419606	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs374874756	chr19:45419607-45419608	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs190304337	chr19:45419611-45419612	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs370058972	chr19:45419612-45419613	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs547484031	chr19:45419614-45419615	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs369257939	chr19:45419622-45419623	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs75484466	chr19:45419631-45419632	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs545137772	chr19:45419719-45419720	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs555051945	chr19:45419737-45419738	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs368274886	chr19:45419755-45419756	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs556582009	chr19:45419760-45419761	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs570373032	chr19:45419773-45419774	Weak transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs538939650	chr19:45419802-45419803	Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs558762418	chr19:45419803-45419804	Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs572284214	chr19:45419807-45419808	Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs541149168	chr19:45419820-45419821	Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs371824709	chr19:45419862-45419863	Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs554613064	chr19:45419911-45419912	Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:76)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Astrocytoma	22246337	CNVD
Ovarian cancer	22174824	CNVD
Ovarian cancer	20800559	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Spondylocostal dysostosis	21085971	CNVD
Nicotine metabolism	21956041	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Glioblastoma multiforme	17002787	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	16750200	CNVD
Colorectal cancer	20459617	CNVD
Adrenocortical carcinoma	18281524	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Muscular dystrophy	17160897	CNVD
Multiple myeloma	16616336	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Lung cancer	18438408	CNVD
Breast cancer	22522925	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	17440070	CNVD
Pancreatic cancer	17952125	CNVD
Ovarian cancer	21240255	CNVD

Chromatin state (count:360 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:45417400-45419000	Active TSS	H9 Cell Line	embryonic stem cell
2	chr19:45417400-45419000	Active TSS	Brain Germinal Matrix	brain
3	chr19:45417400-45419000	Active TSS	Fetal Brain Female	brain
4	chr19:45417400-45419200	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr19:45417600-45419000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr19:45417600-45419000	Active TSS	Brain Anterior Caudate	brain
7	chr19:45417600-45419000	Active TSS	Osteobl	bone
8	chr19:45417800-45419000	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
9	chr19:45417800-45419000	Active TSS	HUES48 Cell Line	embryonic stem cell
10	chr19:45417800-45419000	Active TSS	HUES64 Cell Line	embryonic stem cell
11	chr19:45417800-45419000	Active TSS	iPS-18 Cell Line	embryonic stem cell
12	chr19:45417800-45419000	Active TSS	iPS-20b Cell Line	embryonic stem cell
13	chr19:45417800-45419200	Active TSS	A549	lung
14	chr19:45418000-45419000	Active TSS	H1 Cell Line	embryonic stem cell
15	chr19:45418000-45419000	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
16	chr19:45418000-45419000	Active TSS	HUES6 Cell Line	embryonic stem cell
17	chr19:45418000-45419000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr19:45418000-45419000	Active TSS	Primary T regulatory cells fromperipheralblood	blood
19	chr19:45418000-45419000	Flanking Active TSS	Fetal Muscle Trunk	muscle
20	chr19:45418200-45419000	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
21	chr19:45418200-45419000	Active TSS	Liver	Liver
22	chr19:45418200-45419000	Active TSS	Brain Cingulate Gyrus	brain
23	chr19:45418200-45419000	Active TSS	Brain Inferior Temporal Lobe	brain
24	chr19:45418200-45419000	Active TSS	K562	blood
25	chr19:45418400-45419000	Active TSS	Primary T helper cells PMA-I stimulated	--
26	chr19:45418400-45419000	Active TSS	Fetal Intestine Large	intestine
27	chr19:45418400-45419000	Active TSS	HUVEC	blood vessel
28	chr19:45418600-45419000	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr19:45418600-45419000	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr19:45418600-45419400	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr19:45418600-45419400	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
32	chr19:45418600-45419600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
33	chr19:45418600-45421200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr19:45418800-45419000	Enhancers	Primary B cells from peripheral blood	blood
35	chr19:45418800-45419000	Flanking Active TSS	Primary T cells fromperipheralblood	blood
36	chr19:45418800-45419000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
37	chr19:45418800-45419000	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
38	chr19:45418800-45419000	Enhancers	Skeletal Muscle Male	skeletal muscle
39	chr19:45418800-45419000	Enhancers	Stomach Smooth Muscle	stomach
40	chr19:45418800-45419000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
41	chr19:45418800-45419000	Enhancers	NH-A	brain
42	chr19:45418800-45419400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr19:45418800-45419400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
44	chr19:45418800-45419400	Weak transcription	Adipose Nuclei	Adipose
45	chr19:45418800-45419400	Weak transcription	Rectal Mucosa Donor 29	rectum
46	chr19:45418800-45419400	Flanking Active TSS	HepG2	liver
47	chr19:45418800-45419600	Enhancers	Fetal Muscle Leg	muscle
48	chr19:45418800-45419600	Enhancers	Placenta	Placenta
49	chr19:45418800-45427400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
50	chr19:45418800-45427600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links